继续使用血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂，直至获得更多关于2019冠状病毒病（COVID-19）的证据。 - Suppr

Continue ACE inhibitors / ARB'S till further evidence in coronavirus disease 2019 (COVID-19).

作者信息

Bansal Sandeep, Agstam Sourabh, Gupta Anunay, Gupta Preeti, Isser H S

机构信息

Department of Cardiology, VMMC and Safdarjung Hospital, New Delhi, India.

出版信息

Indian Heart J. 2020 May-Jun;72(3):212-213. doi: 10.1016/j.ihj.2020.04.007. Epub 2020 May 7.

DOI:10.1016/j.ihj.2020.04.007

PMID:32405087

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7218667/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/177b/7411117/161ae8caa089/gr1.jpg

相似文献

Continue ACE inhibitors / ARB'S till further evidence in coronavirus disease 2019 (COVID-19).

Indian Heart J. 2020 May-Jun;72(3):212-213. doi: 10.1016/j.ihj.2020.04.007. Epub 2020 May 7.

The COVID-19 outbreak: a snapshot from down under.

Expert Rev Anticancer Ther. 2020 Jun;20(6):433-436. doi: 10.1080/14737140.2020.1766974. Epub 2020 May 18.

[Drugs that aggravate the course of COVID-19 : really ?].

Rev Med Suisse. 2020 Apr 29;16(N° 691-2):852-854.

Dermatology staff participate in fight against Covid-19 in China.

J Eur Acad Dermatol Venereol. 2020 May;34(5):e210-e211. doi: 10.1111/jdv.16390.

A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019).

N Z Med J. 2020 Apr 3;133(1512):85-87.

Rehabilitation Recommendations for Multiple Sclerosis Patients during the COVID-19 Pandemic.

Arch Iran Med. 2020 Jul 1;23(7):509-510. doi: 10.34172/aim.2020.51.

The COVID-19 Outbreak: An Experience for Iranian Health Systems and Orthopedics Association.

Arch Iran Med. 2020 Aug 1;23(8):570-571. doi: 10.34172/aim.2020.63.

Covid-19, the pandemic war: Implication for neurologists.

Rev Neurol (Paris). 2020 May;176(4):223-224. doi: 10.1016/j.neurol.2020.03.002.

How to Protect Older Adults With Comorbidities During Phase 2 of the COVID-19 Pandemic: Nurses' Contributions.

J Gerontol Nurs. 2020 Sep 1;46(9):7-8. doi: 10.3928/00989134-20200811-02.

Clinical considerations for patients with diabetes in times of COVID-19 epidemic.

Diabetes Metab Syndr. 2020 May-Jun;14(3):211-212. doi: 10.1016/j.dsx.2020.03.002. Epub 2020 Mar 10.

引用本文的文献

Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention.

Pharmacol Rep. 2021 Dec;73(6):1539-1550. doi: 10.1007/s43440-021-00303-6. Epub 2021 Jun 27.

Cardiovascular manifestations of COVID-19: An evidence-based narrative review.

Indian J Med Res. 2021;153(1 & 2):7-16. doi: 10.4103/ijmr.IJMR_2450_20.

Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinion.

Diabetes Metab Syndr. 2021 Jan-Feb;15(1):55-62. doi: 10.1016/j.dsx.2020.11.014. Epub 2020 Nov 20.

本文引用的文献

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.

N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.

SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?

Eur Heart J. 2020 May 14;41(19):1801-1803. doi: 10.1093/eurheartj/ehaa235.

Prevalence of hypertension among Indian adults: Results from the great India blood pressure survey.

Indian Heart J. 2019 Jul-Aug;71(4):309-313. doi: 10.1016/j.ihj.2019.09.012. Epub 2019 Sep 18.

Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker.

Am J Hypertens. 2015 Jan;28(1):15-21. doi: 10.1093/ajh/hpu086. Epub 2014 May 18.

Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.

Clin Sci (Lond). 2012 Dec;123(11):649-58. doi: 10.1042/CS20120162.

Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1-7 mas receptor.

Free Radic Res. 2012 Jul;46(7):850-60. doi: 10.3109/10715762.2012.684878. Epub 2012 May 14.

Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1-7 mas receptor.

Mol Cell Endocrinol. 2012 Apr 4;351(2):208-19. doi: 10.1016/j.mce.2011.12.010. Epub 2011 Dec 19.

Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes.

J Card Fail. 2009 Sep;15(7):565-71. doi: 10.1016/j.cardfail.2009.01.014. Epub 2009 Mar 17.

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

Circulation. 2005 May 24;111(20):2605-10. doi: 10.1161/CIRCULATIONAHA.104.510461. Epub 2005 May 16.

Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation.

J Hypertens. 2004 Oct;22(10):1971-6. doi: 10.1097/00004872-200410000-00020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Continue ACE inhibitors / ARB'S till further evidence in coronavirus disease 2019 (COVID-19).

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献